thetaOwl

AMZN

Amazon.com, Inc.Close $265.01EOD only
Max Pain
$260.00
Next expiry May 22, 2026
Expected Move
±$5.47
2.1% from close
Price Gap
-5.01
Distance to max pain
IV Rank
12
Low premium
P/C OI
0.58
Slightly call-heavy
Consensus
8.5/10
Bullish tilt
Published snapshot: May 20, 2026 close
End-of-day snapshot

This page reflects AMZN options positioning from the latest published market-close snapshot. Intraday price and contract changes are not displayed.

Published Snapshot
May 20, 2026 close
AMZN Earnings Report
Analysis based on market close April 2, 2026

Historical consensus-supported lens with full content, report chain context, and metric rail.

You are viewing an older report from April 2, 2026. A newer earnings report is available for May 20, 2026.

View latest report

Earnings Verdict

Earnings on 4/30 (28 days out). IV for the 5/01 expiration is extremely elevated (43.5% vs ~32% nearby), creating a powerful IV crush setup. Historical EPS beat rate is strong, but the 9.7% expected move is historically large. The stock is above max pain with strong pinning GEX, favoring defined-risk premium-selling strategies.

Confidence:
7.5 / 10
base 5; +1 for explicit earnings date (4/30) and massive IV kink; +1 for historical EPS beat rate (100% last 3 quarters); +0.5 for pinning regime; +0.5 for elevated EM vs typical; -0.5 for mixed flow and large OTM put hedging
Most important: IV term structure kink at 5/01 expiration (43.5% vs 32.5% 4/24) confirms earnings premium. The 9.7% EM is wide, but historical EPS beats suggest contained upside risk.
📅Earnings date confirmed for 4/30 (28 days out). IV kink at 5/01 expiration solidifies this.
IV for 5/01 is 43.5% vs ~32% for nearby expirations, indicating a ~11 vol point premium for the event—a strong crush setup.
📈Historical EPS beat rate is 100% over the last 3 reported quarters, with consistent positive surprises.
🔄Delta from prior report: Spot moved up from $205 to $209.77 (above max pain), GEX increased significantly (+$354M vs +$160M), and net flow became more negative. EM tightened slightly (9.7% vs 10.4%).

Regime Classification

Vol Regime
Normal (IV 37%)
Gamma Regime
Pinning (GEX +$354.0M — mean-reverting)
Flow Regime
Mixed (net prem $-15.6M, P/C 0.96)
Spot vs MP
Above max pain by 2.3% (spot $209.77 vs MP $205)

Earnings Overview

Next earnings: 2026-04-30 (28 days)explicit (EPS estimate provided) + IV kink at 5/01

Expected moves:

  • 5/01 (29d): ±$20.27 (9.7%) [$189.50 - $230.05]

IV Setup

Term structure: Massive kink at 5/01 expiration: IV jumps to 43.5% from 32.5% (4/24) and drops to 42.3% (5/08). Nearby expirations (4/06-4/24) range from 20.7%-32.5%.

Crush estimate: ~10-11 vol pts post-event, back to ~33-34% (consistent with 5/08-5/15 levels).

Skew: P/C volume ratio 0.96 suggests balanced volume, but net premium flow is negative (-$15.6M) driven by massive put premium at $245.

Historical Context

Beat rate: 100% (3/3 quarters with data)

Avg move vs expected: N/A (no historical move data provided)

Directional bias: N/A

Key Levels

1Max Pain: $205 (near-term)
2Spot: $210
3EM 5/01 Lower Bound: $190
4EM 5/01 Upper Bound: $230
5Call OI Walls: $275, $300, $250
6Put OI Support: $205, $200

Flow Highlights

Massive net put premium at $245 (-$38.1M).

Extreme OTM (~17% below spot) institutional hedging or tail-risk protection for the earnings period, not a near-term directional bet.

Significant net call premium at $210 (+$5.3M) and $207.50 (+$4.9M).

Bullish flow near the current spot, potentially earnings-related upside bets or call spreads.

Unusual put buying in 4/06 $187.50P (2,612 vol, 21.9x OI, IV 42.4%).

Near-term bearish bet or hedge, but expiration is before earnings. Suggests some near-term downside concern.

Strategies

Iron Condor (Defined Risk Premium Sell)
Sell 5/01 $190 Put / Buy 5/01 $185 Put | Sell 5/01 $225 Call / Buy 5/01 $230 Call
Credit: $3.00-$3.60
Max loss: $2.00
Max gain: $3.30
BE: $186.70 to $228.30 (approx)
Trigger: Enter 7-10 days before earnings (around 4/20-4/23).
Capitalizes on elevated IV (43.5%) with defined risk. Strikes are placed inside the EM but capture a wide 16.7% range. Historical EPS beat tendency and pinning regime support a contained reaction. Positive GEX reinforces mean reversion.
Outperforms: Stock stays within $190-$225 through expiration and IV crushes.
Underperforms: Stock gaps beyond the short strikes, especially below $190.
Short Strangle (Aggressive Premium Sell)
Sell 5/01 $185 Put & Sell 5/01 $230 Call
Credit: $10.00-$12.00
Max loss: Unlimited
Max gain: $11.00
BE: $173.00 to $242.00 (approx)
Trigger: Enter 5-7 days before earnings (around 4/23-4/25) if IV remains elevated.
Maximizes premium collected from the extreme IV kink. Strikes are at the edges of the expected move, providing a buffer. The high credit offers a large cushion. Best for those with high conviction in a contained move.
Outperforms: Stock stays within a very wide range ($185-$230) and IV crushes post-earnings.
Underperforms: Stock gaps beyond the short strikes, with undefined risk.
Put Calendar Spread (IV Crush Play)
Buy 4/24 $205 Put & Sell 5/01 $205 Put
Credit: $2.20-$2.80
Max loss: $2.80
Max gain: $2.50
BE: Complex; best if stock is near $205 at 4/24 close with high IV on the short 5/01 put.
Trigger: Enter on a spot move toward $210 or higher, 10-14 days before earnings.
Exploits the massive IV differential (32.5% vs 43.5%) between expirations bracketing earnings. Positive theta play that benefits specifically from the IV crush on the short 5/01 leg. Max pain at $205 supports pinning through 4/24.
Outperforms: Stock is near $205 at 4/24 expiry and the IV in the 5/01 put collapses post-earnings.
Underperforms: Large immediate move away from $205 before 4/24 expiry.
Long Straddle (Directional Volatility)
Buy 5/01 $210 Straddle
Max loss: $20.27
Max gain: Unlimited
BE: $189.73 to $230.27 (approx, depends on debit)
Trigger: Enter 1-2 days before earnings if IV hasn't spiked further.
High-risk play betting on a larger-than-expected move. Justified only if you believe the 9.7% EM underestimates potential volatility from guidance or macro factors. Historical EPS beat tendency is a headwind for a large downside move.
Outperforms: Actual move exceeds EM by >15-20% (i.e., move > ±11.2%).
Underperforms: Stock pins near $210 and IV crushes heavily post-earnings.

Risk Assessment

!Gap Risk: The 9.7% expected move is historically large for AMZN. A guidance surprise on AWS or retail margins could cause a gap beyond the EM bounds.
!IV Crush Magnitude: Estimated crush of 10-11 vol points is significant. This is the primary profit driver for premium-selling strategies.
!Time Decay: With 28 days to earnings, theta decay accelerates in the final two weeks. Optimal entry for short premium is 7-10 days out.
!Flow Shift: Net flow remains negative (-$15.6M vs prior -$8.4M), with persistent massive OTM put hedging at $245. This indicates institutional caution and provides a floor of demand for puts.
!Liquidity: Excellent liquidity in AMZN options. No concerns.
!Sizing: Given the extended time to event and binary risk, use reduced size for premium-selling strategies initially, potentially adding closer to earnings.

What to Watch

?Spot price action relative to the $205 max pain level in the weeks leading to earnings. A move back toward $205 would improve pinning odds.
?IV trajectory for the 5/01 expiration; a further rise would improve premium-selling entry.
?Any unusual activity in 5/01 OTM puts (e.g., $190, $185) for clues on downside hedging.
?Broader market volatility (VIX) as a proxy for post-earnings IV floor.
How to Use These Reports
This earnings reflects the market close on April 2, 2026.
What the reports do

Each report translates the same market-close options snapshot into a specific lens such as directional bias, premium-selling posture, flow quality, or earnings setup.

How traders use them

Reports are most useful for narrowing the playbook, surfacing entry and risk context, and deciding which raw data page to inspect next.

What to remember

These are interpretation layers, not execution guarantees. Validate the setup against chain liquidity, expected move, and exposure before sizing risk.

If the report conviction and the raw data disagree, slow down and resolve the mismatch before sizing risk.